Monica López‐Duarte

Author

Monica López‐Duarte

Marqués de Valdecilla University Hospital ORCID

Also Known As

M Lopez-Duarte, M. L. Uria Oficialdegui, M. Lopez-Duarte, M. López‐Duarte, Monica Lopez Duarte, Monica Lopez-Duarte, Monica López‐Duarte, Mónica López, Mónica López-Duarte, Mónica López‐Duarte

Publications

445

Citations

H-Index

Concepts

All Affiliations

Marqués de Valdecilla University Hospital Hospital Universitari i Politècnic La Fe Hospital de Sant Pau Hospital Universitario Virgen del Rocío Hospital Sant Joan de Déu Barcelona

About

Monica López‐Duarte is an author at Marqués de Valdecilla University Hospital specializing in medicine, molecular diagnostics, and dna replication.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	159
2	Natural Sciences	1	1	34
3	Cellular Therapies	1	1	26
4	Immunology	1	1	26
5	Molecular Biology	1	1	34

Monica López‐Duarte

Publications

379

Citations

H-Index

Page 1

	Year	Citations
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation Rodrigo Martino, Rocío Parody, Takahiro Fukuda, Blood	2006	129
Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections César Sanz-Rodrı́guez, Monica López‐Duarte, M. Jurado, Bone Marrow Transplantation Antifungal AgentVaginitisMedicinal FungiInvasive Fungal InfectionsInfection Control	2004	84
Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome‐positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL‐94, ALL‐99 and ALL‐2005 Susana Rives, Jesús Estella, Pedro Gómez, British Journal of Haematology	2011	55
Indel analysis by droplet digital PCR: a sensitive method for DNA mixture detection and chimerism analysis Ana Santurtún, José A. Riancho, Jana Arozamena, International Journal of Legal Medicine Dna SequencingMedicineGeneticsNatural SciencesDna Analysis	2016	34
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia Valeria Ceolin, Erica Brivio, Harm van Tinteren, Leukemia Inotuzumab OzogamicinHematological MalignancyCell TherapyPediatric HematologyHematology	2022	26
Blinatumomab and inotuzumab for B cell precursor acute lymphoblastic leukaemia in children: a retrospective study from the Leukemia Working Group of the Spanish Society of Pediatric Hematology and Oncology (SEHOP) José Luís Fuster, Águeda Molinos-Quintana, Carolina Fuentes, British Journal of Haematology	2020	24
A Prospective Controlled Study of a Computer-Assisted Acenocoumarol Dosage Program Fernando Marco, Carmen Sedano, Arancha Bermúdez, Pathophysiology of Haemostasis and Thrombosis ThrombosisTherapeutic Drug MonitoringTraditional DosageClinical TherapeuticPharmacology	2003	15
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia Roser Pujol, Jordi Minguillón, Massimo Bogliolo, American Journal of Hematology	2024	12

Page 1